European Malignant Hyperthermia Group
  • About
  • News Meetings Education
  • General Testing for MH Genetics PatientInformation
  • Recommendations
  • Grants
  • MH units
  • Contact
  • Links
  • Find
  • Sign In My Account
European Malignant Hyperthermia Group
  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account
European Malignant Hyperthermia Group

Recommendations

European Malignant Hyperthermia Group
  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account

Recommendations

In addition to the guidelines for MH diagnosis the European Malignant Hyperthermia Group has issued the following recommendations. 

Featured
Nov 4, 2024
Recognising and managing a malignant hyperthermia crisis (v2024)
Nov 4, 2024
Nov 4, 2024
May 9, 2024
Life insurance and MH
May 9, 2024
May 9, 2024
Jan 19, 2021
Perioperative management of known or suspected MHS
Jan 19, 2021
Jan 19, 2021
Aug 26, 2020
Dantrolene availability
Aug 26, 2020
Aug 26, 2020
Jul 28, 2020
Occupational exposure to volatile anaesthetics
Jul 28, 2020
Jul 28, 2020
May 20, 2019
Malignant hyperthermia during pregnancy
May 20, 2019
May 20, 2019
Feb 27, 2018
Perioperative Management of MH Suspected or Susceptible Patients
Feb 27, 2018
Feb 27, 2018
Feb 27, 2018
Preparation of Anaesthetic Workstations for MH suspected or susceptible patients
Feb 27, 2018
Feb 27, 2018
Dec 30, 2017
Management of MH crisis
Dec 30, 2017
Dec 30, 2017
Dec 30, 2017
in-vitro contracture testing
Dec 30, 2017
Dec 30, 2017
December 30, 2017

in-vitro contracture testing

December 30, 2017/ Thierry Girard

In addition to the guideline for the investigation of MH susceptibility, there are the following recommendations:

  • Ryanodine muscle contracture testing (optional test)
  • 4-chloro-m-kresol bolus test
  • Cryopreservation of muscle tissue
December 30, 2017/ Thierry Girard/

Thierry Girard

  • Management of MH crisis
  • Recommendations
  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account

European Malignant Hyperthermia Group

EMHG

The EMHG constitution
The Executive Committee
Quality Assurance Program
Membership
Contact us
signup for membership

Specialist society member

privacy policy